ralphey@ Searching for the org video on Valsartan tragedy - I came across this very telling webpage:
Summary:
While the US has a rigorous approval process for new drugs, generic drug suppliers are lightly regulated.
90% of all American prescriptions are generics and at least 80% of their ingredients derive from Chinese and Indian factories using raw materials from unknown sources.
Former FDA inspectors report rusting and discolored equipment in overseas facilities.
In 2018, it was discovered that China’s Huhai Pharma, a major supplier to generic manufacturers of valsartan blood pressure medication, switched to a different solvent while ignoring cancer-causing side-effects.
I think - if if some of you 'bright pro doctors' - found a way to 'Reach Anna Edney' about the US population 'being denied the access to Branch CDV saving Drug Vascepa' the Lady might understand the significance and seriousness of this problem.
Market Data 
Markets 
AI
